Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Padoan

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Autoimmunity Reviews|July 27, 2025
Primordial and primary prevention in rheumatological diseases: The time has comeLaura Scagnellato, Mariangela Salvato, Luca Iorio, et al.
Rheumatology (Oxford, England)|October 16, 2024
Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitisRoberto Padoan, Federica Davanzo, Luca Iorio, et al.
Frontiers in Immunology|October 6, 2025
Antineutrophil cytoplasmic antibody-associated vasculitis: insights into relapse risk and future management directionsFederico Alberici, Oliver Flossmann, Peter Lamprecht, et al.
Diagnostics (Basel, Switzerland)|March 13, 2024
Cutting-Edge Strategies for Renal Tumour-like Lesions in Granulomatosis with Polyangiitis: A Systematic ReviewLuca Iorio, Marco Pizzi, Diego Cecchin, et al.
Clinical and Experimental Rheumatology|May 23, 2020
Renal involvement at baseline can predict major renal relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitisMara Felicetti, Michela Gasparotto, Anna Chiara Frigo, et al.
Expert Opinion on Biological Therapy|May 7, 2019
Cogan's syndrome: new therapeutic approaches in the biological eraRoberto Padoan, Diego Cazzador, Alfonso Luca Pendolino, et al.
Clinical and Experimental Rheumatology|May 20, 2021
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitisSara Monti, Mara Felicetti, Paolo Delvino, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 14, 2018
Overall Disability Sum Score for Clinical Assessment of Neurological Involvement in Eosinophilic Granulomatosis With PolyangiitisRoberto Padoan, Maddalena Marconato, Mara Felicetti, et al.
Expert Opinion on Biological Therapy|January 10, 2024
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidenceMarco Caminati, Claudio Micheletto, Francesca Norelli, et al.
American Journal of Otolaryngology|August 19, 2020
Nasal polyps in eosinophilic granulomatosis with polyangiitis: Structured histopathology and CD105 expressionGiuseppe Brescia, Roberto Padoan, Franco Schiavon, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Autoimmunity Reviews|July 27, 2025
Primordial and primary prevention in rheumatological diseases: The time has comeLaura Scagnellato, Mariangela Salvato, Luca Iorio, et al.
Rheumatology (Oxford, England)|October 16, 2024
Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitisRoberto Padoan, Federica Davanzo, Luca Iorio, et al.
Frontiers in Immunology|October 6, 2025
Antineutrophil cytoplasmic antibody-associated vasculitis: insights into relapse risk and future management directionsFederico Alberici, Oliver Flossmann, Peter Lamprecht, et al.
Diagnostics (Basel, Switzerland)|March 13, 2024
Cutting-Edge Strategies for Renal Tumour-like Lesions in Granulomatosis with Polyangiitis: A Systematic ReviewLuca Iorio, Marco Pizzi, Diego Cecchin, et al.
Clinical and Experimental Rheumatology|May 23, 2020
Renal involvement at baseline can predict major renal relapse in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitisMara Felicetti, Michela Gasparotto, Anna Chiara Frigo, et al.
Expert Opinion on Biological Therapy|May 7, 2019
Cogan's syndrome: new therapeutic approaches in the biological eraRoberto Padoan, Diego Cazzador, Alfonso Luca Pendolino, et al.
Clinical and Experimental Rheumatology|May 20, 2021
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitisSara Monti, Mara Felicetti, Paolo Delvino, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 14, 2018
Overall Disability Sum Score for Clinical Assessment of Neurological Involvement in Eosinophilic Granulomatosis With PolyangiitisRoberto Padoan, Maddalena Marconato, Mara Felicetti, et al.
Expert Opinion on Biological Therapy|January 10, 2024
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidenceMarco Caminati, Claudio Micheletto, Francesca Norelli, et al.
American Journal of Otolaryngology|August 19, 2020
Nasal polyps in eosinophilic granulomatosis with polyangiitis: Structured histopathology and CD105 expressionGiuseppe Brescia, Roberto Padoan, Franco Schiavon, et al.
Pageof 8